Dipna Pharmachem IPO listing price is ₹ 33.40, issue price is ₹ 38.00, and currently trading at ₹ 23.02 as on May 13, 2025. Dipna Pharmachem IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Dipna Pharmachem IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Interactive Financial Services is the merchant banker of Dipna Pharmachem IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 14th July 2022.
Dipna Pharmachem IPO offer price is ₹ 38.00 and got listed at ₹ 33.40. Read Dipna Pharmachem IPO details mentioned above.The IPO of Dipna Pharmachem Limited was listed on 8th September 2022. As of today, Dipna Pharmachem IPO is trading at ₹ 23.02, compared to the previous day’s close of ₹ 22.57. Read the report above for detailed IPO performance.
The issue price of Dipna Pharmachem IPO was ₹ 38.00 per equity share.
Dipna Pharmachem IPO was listed at ₹33.40 on the stock exchange on 8th September 2022. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 13, 2025, the current market price of Dipna Pharmachem IPO is ₹ 23.02.
The 52-week high for Dipna Pharmachem IPO is ₹ 23.85, while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Dipna Pharmachem IPO listed at ₹ 33.40 against the issue price of ₹ 38.00 per equity share, showing a listing day gain/loss of -4.6 (-12.11%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Dipna Pharmachem IPO stock moved from its listing price of ₹ 33.40 to the current price of ₹23.02 per equity share, reflecting a change of -31.08% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Dipna Pharmachem IPO issue date of May 13, 2025 and CMP of ₹23.02, the estimated CAGR is approximately -17.04%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Dipna Pharmachem IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Dipna Pharmachem Financial Review Page
Merchant Banker(s) of Dipna Pharmachem IPO: Interactive Financial Services Limited
Dipna Pharmachem IPO subscription was 2.77 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Dipna Pharmachem IPO listed at a listing price of 33.40 against the offer price of 38.00.
The current market price of Dipna Pharmachem is 23.02.
Why Us?